Plus Therapeutics Inc (NASDAQ:PSTV) price on Thursday, May 22, fall -7.72% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.31.
A look at the stock’s price movement, the close in the last trading session was $0.34. Turning to its 52-week performance, $2.67 and $0.24 were the 52-week high and 52-week low respectively. Overall, PSTV moved -68.17% over the past month.
Plus Therapeutics Inc’s market cap currently stands at around $5.32 million, with investors looking forward to this quarter’s earnings report slated for in June.
The average forecast suggests down to a -33.66% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 4.86M, representing a -16.51% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PSTV is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
PSTV’s current price about -45.49% and -58.98% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 33.76, while 7-day volatility ratio is 12.00% and 11.36% in the 30-day chart. Further, Plus Therapeutics Inc (PSTV) has a beta value of 0.72, and an average true range (ATR) of 0.12.
If we refocus on Plus Therapeutics Inc (NASDAQ:PSTV), historical trading data shows that trading volumes averaged 17.63 million over the past 3 months. The company’s latest data on shares outstanding shows there are 17.00 million shares.
The 2.55% of Plus Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 9.41% of the company’s shares. Current price change has pushed the stock -72.78% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PSTV stock continues to rise going into the next quarter.
